Pharmacokinetic Study of E7080/Lenvatinib in Chinese Subjects With Solid Tumor
Clinical trial NCT03009292 · COMPLETED
Trial details
- NCT number
- NCT03009292
- Sponsor
- Eisai Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-06
- Primary completion
- 2018-12-24
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.